MEDICATON MANAGEMENT OF SIDE EFFECTS WHEN ADHD PATIENTS ARE CO MORBID FOR ASPERGER S SYNDROME OR ANXIETY DISORDERS

Size: px
Start display at page:

Download "MEDICATON MANAGEMENT OF SIDE EFFECTS WHEN ADHD PATIENTS ARE CO MORBID FOR ASPERGER S SYNDROME OR ANXIETY DISORDERS"

Transcription

1 MEDICATON MANAGEMENT OF SIDE EFFECTS WHEN ADHD PATIENTS ARE CO MORBID FOR ASPERGER S SYNDROME OR ANXIETY DISORDERS

2 EDWARD B. AULL, M.D N. MERIDIAN SUITE 354 CARMEL, INDIANA FAX BEHAVIORAL PEDIATRICS

3 DISCLOSURE I have no actual or potential conflict of interest in relation to this program/presentation.

4 DISCLOSURES Grant/Research support: none Speaker s Bureau: None in the past three years. Consultant: None in the past five years. Major Shareholder: none I published a book related to this topic entitled, The Parents Guide to the Medical World of Autism.

5 DISCLOSURES I will be discussing the use of SSRI s such as Paxil, Prozac, Zoloft, Celexa, Lexapro in the care of autism for which they are not approved, however they are approved for use in anxiety and depression for which their use will be discussed. I will be discussing the use of atypical antipsychotics two of which are approved for the treatment of autism spectrum disorders, but others have not yet been approved. I will be discussing the use of ADHD medications in autism for which they are not FDA approved but their usage will be discussed in the treatment of ADHD symptoms for which they are approved.

6 DSM-IV 1994 PERVASIVE DEVELOPMENTAL DISORDERS AUTISM, ASPERGER S SYNDROME, PDD-NOS RETTS CHILDHOOD DISINTEGRATIVE DISORDER DID NOT ALLOW ASD AND ADHD

7 DSM AUTISM SPECTRUM DISORDERS ELIMINATES ASPERGER S SYNDROME AND PDD- NOS WILL HAVE SEVERITY ASSESMENTS WILL ALLOW COMORBIDITIES SUCH AS ADHD AND ANXIETY DISORDERS ONE LINE SUGGESTS THOSE FORMERLY CALLED ASPERGER S.

8 CO MORBID DISORDERS THREE FOURTHS OF PATIENTS WITH AUTISM SPECTRUM DISORDERS MEET CRITERIA FOR OTHER PSYCHIATRIC DISORDERS ADHD, ANXIETY DISORDERS, AFFECTIVE DISORDERS BRERETON, ET AL 2006

9 ASD I DEFINE AUTISM SPECTRUM DISORDERS AS A MIX OF ADHD, ANXIETY, AND A LANGUAGE- BASED LEARNING DISABILITY, IN THAT THEY TAKE LANGUAGE TOO LITERALLY, AND DON T READ BODY LANGUAGE WELL

10 ASD PATIENTS WITH ASD S ARE TYPICALLY VERY SENSITIVE TO EVEN SMALL DOSAGE CHANGES OF MEDICATIONS OUTCOMES SUCH AS SEDATION AND ACTIVATION MAY BE QUITE VARIABLE CAUSE OF UNIQUE REACTIONS IS UNKNOWN

11 ASD ADHD AND ANXIETY ARE SEEN AS COMORBIDITIES IN 30 TO 85% OF PATIENTS WITH ASD S IN MANY STUDIES RECENT STUDY (HANSON, ET AL 2013) SHOWED AN INCIDENCE OF ADHD OF ONLY 2-16%, HOWEVER, TYPICAL ADHD QUESTIONAIRES WERE NOT UTILIZED, USED CBCL

12 White Matter Microstructure Predicts Autistic Traits in ADHD Cooper, et. al. J. Autism Dev Disord ( Nov 2014) Cardiff Univ. School of Medicine White matter micostructural signature of autistic traits in ADHD. Abnormal sociocommunicative traits in ADHD appear to have association with the neurobiology of phenotypic variation in ADHD even in those who do not have a known ASD diagnosis.

13 ADHD MEDICATIONS STIMULANT MEDICATIONS WORK PRIMARILY THROUGH INCREASING THE EFFECTS OF DOPAMINE DOPAMINE AGGRAVATES ANXIETY THOSE THAT WORK PRIMARILY THROUGH INCREASING NOREPINEPHRINE, TEND NOT TO INCREASE ANXIETY BUT THEY DO NOT IMPROVE IT EITHER

14 ADHD MEDICAITONS IN ASD MOST STUDIES IN PATIENTS WITH ASD S SHOW LESS ROBUST EFFECTS ON ADHD AND GREATER INCIDENCES OF SIDE EFFECTS AND MORE SIGNIFICANT SIDE EFFECTS

15 Pharmacological treatment of ADHD in PDD Meta-analysis of seven trials with 225 children Methylphenidate is effective with increased side effects including decreased appetite, depression, insomnia, irritability, and social withdrawal Clonidine and atomoxetine may be effective. Reichow, Volkmar, Bloch JADD 2013

16 EFFECT SIZE If tested at two standard deviations off the norm, receives treatment, and then tests one standard deviation off the norm, that is an effect size of one. Average effect size for psychiatric medications is about 0.33

17 TRUE AMPHETAMINES Amphetamines, Adderall, Vyvanse, Dexedrine, Procentra, have the greatest effect size, about 0.9 to 1.2 They also tend to have the most side effects The most even release will likely have the least side effects. In this group Vyvanse is the most even release Two new drugs, one dextroamphetamine salts in more doses, Zenzedi, 5,7.5,10,15,20,30 mg. Second is a mix of dextroamphetamine and levoamphetamine salts, Evekeo, 5,10 mg.

18 AMPHETAMINE EFFECTS Adderall IR 4 to 5 hours Dexedrine IR 4 to 5 hours Adderall XR 11 to 12 hours at appropriate dose Vyvanse 13 to 16 hours at appropriate dose Dexedrine Spansule 8 to 9 hours Patients may be crabby at peak dose or when medication is wearing off

19 AMPHETAMINE SIDE EFFECTS Decreased appetite and interference with sleep tend to be more severe than other stimulants, however, for the great majority of patients, these issues are only significant when first starting the medications Aggravating anxiety, aggravating social quietness, and aggravating lack of tolerance for imperfection in others and sometimes oneself, are common. Anxiety issues may be lessened with the addition of anxiolytic medications such as SSRI s

20 METHYLPENIDATES Ritalin, Focalin, Metadate, Methylin, Daytrana, Quillivant, have effect size of 0.7 to 1.0 Ritalin LA and Focalin XR release 50% morning and lunch Metadate, Concerta, and Quillivant release about 25% at first and about 75% four hours later Daytrana is the most even release and may therefore have less side effects

21 METHYLPHENIDATE SIDE EFFECTS Decreased appetite and interference with sleep tend to be less significant than with true amphetamines 30% of patients may actually have better sleep initiation if their medication is still working and don t have rebound racing thoughts Most patients will suffer less social quietness and pressuring of anxiety on methylphenidates than on amphetamines but some patients are more social on the amphetamines

22 METHYLPHENIDATE EFFECTS IR Ritalin 2.5 to 4.0 hours IR Focalin 4 to 5 hours Concerta 11 to 12 hours at correct dose Daytrana 10 to 12 hours Metadate CD and Focalin XR, 8 to 9 hours May be a rebound sensitivity, easily upset or tearful as the dose wears off

23 NONSTIMULANTS Strattera, Intuniv, Kapvay Last all day Do not aggravate anxiety or social quietness, in fact, may help with social interest and reading social cues Not as potent as the stimulants, Intuniv and Kapvay are often used as adjuncts with a stimulant Sleepiness is the main negative side effect and is variable from person to person May be drugs of preference in patients with autism spectrum disorders

24 OTHER ADHD MEDICATIONS Wellbutrin, Remeron, tricyclics such as imipramine or desipramine May be as potent as a stimulant, but not often Do help with anxiety, appetite, and sleep(?) Tricyclics may be fatal in overdose Vayarin? Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA)

25 ANXIETY 40% of children with ASDs fulfill diagnostic criteria for an anxiety disorder. Van Steensel et al % have impairing anxiety symptoms. White et al Co-occurring anxiety can cause acute distress, amplify the core symptoms of ASD, and trigger behavioral difficulties, including tantrums, aggression and self injury. Canitano 2006

26 ANXIETY AND ADHD STIMULANTS CAN BE USED BUT THE ANXIETY MUST BE PROTECTED USUALLY WITH THE USE OF AN SSRI. IN ASD THE ANXIETY MAY HAVE TO BE TREATED PRIOR TO THE INITIATION OF A STIMULANT. IF THE ANXIETY IS IMMEDIATELY INCREASED WITH A SMALL DOSE OF A STIMULANT, AN ASD SHOULD BE CONSIDERED.

27 ANXIETY SSRI S ARE THE PRIMARY MEDICATIONS USED TO IMPROVE ANXIETY PROZAC, ZOLOFT, AND LEXAPRO ARE FDA APPROVED IN CHILDREN BENZO S SHOULD BE AVOIDED EXCEPT FOR SHORT EVENTS SUCH AS DENTAL VISIT, PLANE TRIP, DELIVER A SPEECH

28 ANXIETY Goals of SSRI treatment: 1 less anxiety, less obsessive behavior, easier transitions 2 better eye contact, better reciprocal conversations 3 disinhibition, so that they can or will do what others want them to do

29 ANXIETY ANXIETY MAY HIDE ADHD, PATIENT WANTS TO PLEASE, NOT BREAK RULES AS ANXIETY IS LOWERED WITH SSRI, MAY EXPOSE ADHD SSRI S DO NOT HAVE ADHD EFFECTS, IF IMPROVED ATTENTION IS NOTED, ANXIETY WAS INTERFERING WITH ATTENTION, RATHER THAN A DIRECT EFFECT ON ATTENTION SNRI S HAVE SOME ADHD EFFECTS

30 ANXIETY ATYPICAL ANTIPSYCHOTICS MAY HAVE TO BE USED TO AUGMENT ANTIANXIETY EFFECTS OF SSRI S. ATYPICAL ANTIPSYCHOTICS MAY IMPROVE SOCIAL INTEREST AND READING OF SOCIAL CUES IN ASD S. ATYPICAL ANTIPSYCHOTICS MAY BE USED FOR OPPOSITIONAL SYMPTOMS AND TICS. GUANFACINE AND CLONODINE MAY OBVIATE THE NEED FOR AN ATYPICAL ANTIPSYCHOTIC.

31 ATYPICAL ANTIPSYCHOTICS Abilify and Risperdal are FDA approved for treatment of aggression and outbursts in autism spectrum disorders Zyprexa, Seroquel, Geodon, Saphris, Fanapt are also used Antipsychotics augment SSRI s in treatment of anxiety and depression Main side effects are weight gain and potential for tardive dyskinesia Effects are quite variable from patient to patient

32 ASD IF ONLY TREAT ADHD, ESPECIALLY WITH STIMULANTS, OFTEN MEDICATON WILL WORK FOR ONLY A FEW MONTHS, OR ANXIETY WILL BE INCREASED AND THE PATIENT WILL GET WORSE TREATING ANXIETY FIRST MAY BE REQUIRED TO TOLERATE ANY DOSE OF A STIMULANT BUT ESPCIALLY A ROBUST DOSE IF REQUIRED FOR ADHD SYMPTOMS

33 ASD THE MORE EVEN THE MEDICATION WILL RESULT IN LESS SIDE EFFECTS. VYVANSE AND DAYTRANA ARE VERY SMOOTH ISOMERS LIKE FOCALIN AND LEXAPRO TEND TO HAVE LESS SIDE EFFECTS NONSTIMULANTS MAY BE PREFERRED IN PATIENTS WITH ASD AND MAY IMPROVE INTEREST IN SOCIAL INTERACTION AND READING OF SOCIAL CUES.

34 SOCIAL ISSUES WITH STIMULANTS AGGRAVATE ANXIETY AGGRAVATE SOCIAL QUIETNESS AGGRAVATE LACK OF TOLERANCE FOR IMPERFECTION IN OTHERS THESE ISSUES ARE ALSO SEEN IN PATIENTS WITH ADHD BUT MAY BE MORE SEVERE OR MORE DEBILITATING IN ASD

35 PATS STUDY Preschool children and treatment with ADHD medications. 76.5% of children had one other diagnosis 29.7% of children had two or more additional diagnoses.

36 QUESTIONS?

A PARENTS GUIDE TO THE MEDICAL TREATMENT OF ADHD WHEN THERE IS ALSO AUTISM OR ASPERGER SYNDROME

A PARENTS GUIDE TO THE MEDICAL TREATMENT OF ADHD WHEN THERE IS ALSO AUTISM OR ASPERGER SYNDROME A PARENTS GUIDE TO THE MEDICAL TREATMENT OF ADHD WHEN THERE IS ALSO AUTISM OR ASPERGER SYNDROME EDWARD B. AULL, M.D. 13450 N. MERIDIAN SUITE 354 CARMEL, INDIANA 46032 317 582 7654 FAX 317 582 7660 BEHAVIORAL

More information

ATTENTION- DEFICIT HYPERACTIVITY DISORDER (ADHD) QUANTITY LIMITATION UTILIZATION MANAGEMENT CRITERIA

ATTENTION- DEFICIT HYPERACTIVITY DISORDER (ADHD) QUANTITY LIMITATION UTILIZATION MANAGEMENT CRITERIA ATTENTION- DEFICIT HYPERACTIVITY DISORDER (ADHD) QUANTITY LIMITATION UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: Stimulants and Non-Stimulants BRAND (generic) NAMES: Adderall (amphetamine/dextroamphetamine)

More information

Medications Used in the Management of Disruptive Behavior Disorders

Medications Used in the Management of Disruptive Behavior Disorders The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.

More information

Complex Patients. Evaluation. ADHD Pharmacotherapy: Stimulant Use and Abuse

Complex Patients. Evaluation. ADHD Pharmacotherapy: Stimulant Use and Abuse ADHD Pharmacotherapy: Stimulant Use and Abuse A Clinical Perspective Thor C. Bergersen, M.D. Complex Patients Rarely do people fit into categorical boxes Constellation of symptoms is the norm ADHD is frequently

More information

Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers

Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers Treatment Options for ADHD in Children and Teens A Review of Research for Parents and Caregivers Is This Summary Right for Me? Yes, if: A doctor said that your child or teen has attention deficit hyperactivity

More information

Medication Management: ADHD

Medication Management: ADHD Medication Management: ADHD March 6, 2004 Pacific Northwest Neuropsychological Society Samuel H. Zinner, M.D. Developmental/Behavioral Pediatrics University of Washington ADHD - Etiology Neurobiology Neurotransmitters

More information

Comorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014

Comorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014 Comorbid Conditions in Autism Spectrum Illness David Ermer MD June 13, 2014 Overview Diagnosing comorbidities in autism spectrum illnesses Treatment issues specific to autism spectrum illnesses Treatment

More information

Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD) Medications

Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD) Medications Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD) Medications Clinical Edit Information Included

More information

The Role of Medication

The Role of Medication Managing Medication for Children and Adolescents with ADHD Treating ADHD in children requires medical, educational, behavioral and psychological interventions. This comprehensive approach to treatment

More information

Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD) Medications

Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD) Medications Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD) Medications Clinical Edit Information Included

More information

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that

More information

Jane Marie Sulzle, DNP, CNS, MS PrairieCare Medical Group, Edina

Jane Marie Sulzle, DNP, CNS, MS PrairieCare Medical Group, Edina Children, Mental Health, and Psychiatric Medication: Empowering parents with information on how to talk to their children about medication and how the medication may impact school performance. Jane Marie

More information

Sigita Plioplys, M.D.

Sigita Plioplys, M.D. Psychiatric Issues in Dravet Syndrome: Focusing on Medications Sigita Plioplys, M.D. Head, Pediatric Neuropsychiatry Clinic Dep. of Child and Adolescent Psychiatry Ann and Robert H. Lurie Children s Hospital

More information

Stimulants and Nonstimulants for ADHD

Stimulants and Nonstimulants for ADHD Stimulants and Nonstimulants for ADHD Stimulants Adderall and Adderall XR (amphetamine mixtures) Concerta (methylphenidate, extended release) Daytrana (methylphenidate topical patch) Dexedrine and Dexedrine

More information

ADHD PRACTISE PARAMETER. IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY

ADHD PRACTISE PARAMETER. IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY ADHD PRACTISE PARAMETER IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY Similar type of idea Similar document Similar document AACAP document Neurobiological condition

More information

Overview of Mental Health Medication Trends

Overview of Mental Health Medication Trends America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription

More information

Behavioral Health Diagnoses, Symptoms, and Interventions for Children Ages 4 and older

Behavioral Health Diagnoses, Symptoms, and Interventions for Children Ages 4 and older Diagnosis Typical symptoms Behavioral interventions known to work (Evidence-informed; Manualized) *Descriptions provided below Trauma-related disorders Post-traumatic stress disorder --------------------------

More information

Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder Attention Deficit Hyperactivity Disorder Spring 2015 Continuing Education John Erramouspe, PharmD, MS Idaho State University College of Pharmacy 208-282-3019 johnerra@pharmacy.isu.edu I have no relevant

More information

Basic Principles in the Pharmacologic Management of ADHD

Basic Principles in the Pharmacologic Management of ADHD Child & Adolescent Psychiatry and Behavioral Medicine Center Basic Principles in the Pharmacologic Management of ADHD Overview Therapy may be indicated in ADHD to address organizational skills deficits

More information

MEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS. Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D.

MEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS. Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D. MEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D. Introduction Tourette Syndrome (TS) or Tourette s Disorder

More information

Autism Spectrum Disorders: An Awareness Level Training for Educators

Autism Spectrum Disorders: An Awareness Level Training for Educators Autism Spectrum s: An Awareness Level Training for Educators Autism is the Fastest-Growing Developmental Disability More common than pediatric cancer, diabetes and AIDS combined Autism increased 172% during

More information

Psychotropic Medication Reference Chart

Psychotropic Medication Reference Chart Psychotropic Medication Reference Chart Appendix 4.14 This chart is not an all-inclusive list of medications. If you have a question regarding the classification of a medication you may consult websites

More information

ADHD Agents (Adult) Prior Authorization Criteria

ADHD Agents (Adult) Prior Authorization Criteria ADHD Agents (Adult) Prior Authorization Criteria Brand Generic Dosage Form Adderall amphetamine/dextroamphetamine oral tablet a Adderall XR amphetamine/dextroamphetamine extended-release oral capsule Concerta

More information

ADHD. Dr. Ellen Hennessy-Harstad DNP, RN, FNP-BC, CPN Indiana University Northwest

ADHD. Dr. Ellen Hennessy-Harstad DNP, RN, FNP-BC, CPN Indiana University Northwest ADHD Dr. Ellen Hennessy-Harstad DNP, RN, FNP-BC, CPN Indiana University Northwest Conflict of Interest The presenter indicates that there is no conflict of interest in this presentation, Objectives 1.

More information

Case Study Activity: Management of Attention-Deficit/Hyperactivity Disorder Answers to Interactive Questions

Case Study Activity: Management of Attention-Deficit/Hyperactivity Disorder Answers to Interactive Questions Case Study Activity: Management of Attention-Deficit/Hyperactivity Disorder Answers to Interactive Questions Case 2: Dosing of Attention-Deficit/Hyperactivity Disorder Medications Activity Preview Optimization

More information

Attention-Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit Hyperactivity Disorder (ADHD) Attention-Deficit Hyperactivity Disorder (ADHD) Possible changes in DSM-V APA, 2010 For older adolescents and adults (>17) confirmatory observations by third parties should be obtained whenever possible.

More information

What is ADHD/ADD and Do I Have It?

What is ADHD/ADD and Do I Have It? What is ADHD/ADD and Do I Have It? ADHD Definition and Symptoms Adults with ADHD Possible Coexistent Conditions Medications and Treatments Additional Resources Works Cited What is Attention Deficit Hyperactivity

More information

Drug Effectiveness Review Project Summary Report ADHD

Drug Effectiveness Review Project Summary Report ADHD Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Evaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price

Evaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price Evaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price Contents Our Recommendations...........................................

More information

Autism Spectrum Disorder: Latest in Prevalence, Diagnosis and Interventions

Autism Spectrum Disorder: Latest in Prevalence, Diagnosis and Interventions Autism Spectrum Disorder: Latest in Prevalence, Diagnosis and Interventions Muhammad Waqar Azeem, MD, DFAACAP, DFAPA Chair, Department of Psychiatry Sidra Medical & Research Center DISCLOSURES: NONE n

More information

Therapies for Children With Autism Spectrum Disorders. A Review of the Research for Parents and Caregivers

Therapies for Children With Autism Spectrum Disorders. A Review of the Research for Parents and Caregivers Therapies for Children With Autism Spectrum Disorders A Review of the Research for Parents and Caregivers Is This Guide Right for the Child in My Care? Yes, if: The child you care for is between 2 and

More information

1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care

1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care PHARMACOLOGY: UPDATES AND REVIEW Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care TOPICS General pharmacology concepts when prescribing for children and adults When

More information

No. 21 November 2012

No. 21 November 2012 No. 21 November 2012 Psychiatric Medication for Children and Adolescents Part 1- How Medications Are Used Medication can be an effective part of the treatment for several psychiatric disorders of childhood

More information

New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care

New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care Post-Test/Rationale EDUCATIONAL OBJECTIVES Upon completion of this activity, participants

More information

Overview of DSM-5: Autism Spectrum Disorder

Overview of DSM-5: Autism Spectrum Disorder Overview of DSM-5: Autism Spectrum Disorder Courtney Burnette, PhD Clinical Psychologist UNM Center for Development and Disability Department of Pediatrics September 20, 2013 Objectives Recognize the changes

More information

Psychopharmacology in the Treatment of OCD, Tics and Related Disorders

Psychopharmacology in the Treatment of OCD, Tics and Related Disorders Psychopharmacology in the Treatment of OCD, Tics and Related Disorders Matthew Hopperstad, MD May 21 st, 2016 Topics Today 1. Evaluation of OCD in children and adolescents 2. Review the treatments for

More information

Psychotropic Medication

Psychotropic Medication Page 1 T I P S F O R P R A C T I C E Psychotropic Medication Psychotropic medications are symptomatic medications that affect attention, emotions, or behaviors. Communication between the physician, NDHHS

More information

Parents Guide to ADHD. Frequently asked questions, treatment options, helpful tips and online resources. Copyright 2014 Child Mind Institute

Parents Guide to ADHD. Frequently asked questions, treatment options, helpful tips and online resources. Copyright 2014 Child Mind Institute Parents Guide to ADHD Frequently asked questions, treatment options, helpful tips and online resources Copyright 2014 Child Mind Institute TABLE OF CONTENTS ADHD BASICS What is ADHD? What s the difference

More information

MEDICATIONS FOR DEPRESSION, ANXIETY, AND OBSESSIVE-COMPULSIVE DISORDER

MEDICATIONS FOR DEPRESSION, ANXIETY, AND OBSESSIVE-COMPULSIVE DISORDER MEDICATIONS FOR DEPRESSION, ANXIETY, AND OBSESSIVE-COMPULSIVE DISORDER Group Main Use Medication Brand/ Generic Form Dose Schedule Dose Range Most Common Side Effects for Group Pros for Group Cautions

More information

Child/Adolescent Attention-Deficit/Hyperactivity Disorder

Child/Adolescent Attention-Deficit/Hyperactivity Disorder Child/Adolescent Attention-Deficit/Hyperactivity Disorder NATIONAL GUIDELINE SUMMARY This evidence-based guideline summary is based on the 202 National Child/Adolescent Attention-Defict/ Hyperactivity

More information

Individuals with attention-deficit/hyperactivity disorder

Individuals with attention-deficit/hyperactivity disorder National Resource Center on AD HD A program of CHADD 3 WHAT WE KNOW Managing Medication for Children and Adolescents with ADHD * Individuals with attention-deficit/hyperactivity disorder (ADHD) experience

More information

Autism Spectrum Disorders and Comorbid Behavioral Health Symptoms

Autism Spectrum Disorders and Comorbid Behavioral Health Symptoms Autism Spectrum Disorders and Comorbid Behavioral Health Symptoms Cynthia King, MD Child and Adolescent Psychiatrist Associate Professor of Psychiatry UNMSOM Psychopharmacologic and Alternative Medicine

More information

Dual Diagnosis in Treatment

Dual Diagnosis in Treatment Dual Diagnosis in Treatment Presented by: Dr. John E. Simon Psychiatrist, Vinland Center 1 John E. Simon, M.D. President, Creative Psychopharmacology Board Certified in Psychiatry Added Qualifications

More information

The following is a sample of psychotropic drug warnings that drug regulatory agencies

The following is a sample of psychotropic drug warnings that drug regulatory agencies Chronology of International Drug Regulatory Agency Warnings about Psychotropic Drugs The following is a sample of psychotropic drug warnings that drug regulatory agencies around the world have issued.

More information

A Guide to Tourette Syndrome Medications by John T. Walkup M.D.

A Guide to Tourette Syndrome Medications by John T. Walkup M.D. llllllllllllllll A TSA MEDICAL PUBLICATION A Guide to Tourette Syndrome Medications by John T. Walkup M.D. This publication is intended to provide information about Tourette Syndrome, its management and

More information

ADHD. Intelligence + Effort = Expected Achievement/ Performance

ADHD. Intelligence + Effort = Expected Achievement/ Performance ADHD Debilitation must be measured against a person s natural potential (e.g. intellectual, emotional) and the effort required to maintain a level of function. Must take into account a person s ability

More information

Neurodevelopmental Disorders, Disruptive, Impulse Control and Conduct Disorder (DSM 5)

Neurodevelopmental Disorders, Disruptive, Impulse Control and Conduct Disorder (DSM 5) Neurodevelopmental Disorders, Disruptive, Impulse Control and Conduct Disorder (DSM 5) Matthew Soulier, MD Paula Wadell, MD Scott Summers, MD, PhD UC Davis Department of Psychiatry CONCENTRATION IRRITABILITY

More information

ADHD ACROSS THE LIFESPAN. Ronald Angoff, MD, FAAP. 7 January 2016

ADHD ACROSS THE LIFESPAN. Ronald Angoff, MD, FAAP. 7 January 2016 ADHD ACROSS THE LIFESPAN Ronald Angoff, MD, FAAP 7 January 2016 $$ I have no commercial ties to disclose $$ DI$CLO$URE 2 GOALS Discuss how ADHD differs in Children and Adults Review current thinking on

More information

ADHD Medication: a Letter from Dr. Gray

ADHD Medication: a Letter from Dr. Gray ADHD MEDICATION ADHD Medication: a Letter from Dr. Gray After specializing in the medical assessment and treatment of ADHD for the past 20 years, I have seen what a positive impact medication can have

More information

The core symptoms of ADHD, as the name implies, are inattentiveness, hyperactivity and impulsivity. These are excessive and long-term and

The core symptoms of ADHD, as the name implies, are inattentiveness, hyperactivity and impulsivity. These are excessive and long-term and Attention Deficit Hyperactivity Disorder What is Attention Deficit Hyperactivity Disorder? The core symptoms of ADHD, as the name implies, are inattentiveness, hyperactivity and impulsivity. These are

More information

Fact Sheet 10 DSM-5 and Autism Spectrum Disorder

Fact Sheet 10 DSM-5 and Autism Spectrum Disorder Fact Sheet 10 DSM-5 and Autism Spectrum Disorder A diagnosis of autism is made on the basis of observed behaviour. There are no blood tests, no single defining symptom and no physical characteristics that

More information

5/9/2014. Attention Deficit Hyperactivity Disorder. Goals and Objectives. Diagnostic Criteria

5/9/2014. Attention Deficit Hyperactivity Disorder. Goals and Objectives. Diagnostic Criteria Attention Deficit Hyperactivity Disorder OVERVIEW, NEUROBIOLOGY AND TREATMENT MARIAN SWOPE, MD MAY 6, 2014 Goals and Objectives Identify the symptoms of ADHD by an increased awareness of the diagnostic

More information

Treatment of Attention Deficit/Hyperactivity Disorder among Children with Special Health Care Needs

Treatment of Attention Deficit/Hyperactivity Disorder among Children with Special Health Care Needs Treatment of Attention Deficit/Hyperactivity Disorder among Children with Special Health Care Needs Susanna N. Visser, DrPH 1, Rebecca H. Bitsko, PhD 1, Melissa L. Danielson, MSPH 1, Reem M. Ghandour,

More information

ADHD (Attention Deficit Hyperactivity Disorder): DSM V Update and Clinical Strategies

ADHD (Attention Deficit Hyperactivity Disorder): DSM V Update and Clinical Strategies ADHD (Attention Deficit Hyperactivity Disorder): DSM V Update and Clinical Strategies Sristi Nath, D.O. Board Certified General Psychiatry Board Certified Child and Adolescent Psychiatry November 8, 2015

More information

Practical Psychopharmacology of Autism Spectrum Disorders

Practical Psychopharmacology of Autism Spectrum Disorders Practical Psychopharmacology of Autism Spectrum Disorders Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Autism Spectrum Disorders and Co-Occurring Mental Health Conditions

Autism Spectrum Disorders and Co-Occurring Mental Health Conditions Autism Spectrum Disorders and Co-Occurring Mental Health Conditions Sydney Rice, MD, MS University of Arizona LEND Erika Ryst, M.D. University of Nevada LEND October 5, 2015 Overview Children with autism

More information

Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.

Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use. Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review

More information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency

More information

ATTENTION DEFICIT HYPERACTIVITY DISORDER AND TUBEROUS SCLEROSIS COMPLEX

ATTENTION DEFICIT HYPERACTIVITY DISORDER AND TUBEROUS SCLEROSIS COMPLEX ATTENTION DEFICIT HYPERACTIVITY DISORDER AND TUBEROUS SCLEROSIS COMPLEX What is ADHD? Attention Deficit Hyperactivity Disorder (ADHD) is a common neurobehavioral disorder. It is usually first diagnosed

More information

Attention Deficit Hyperactivity Disorder: Comparison of Medication Efficacy and Cost

Attention Deficit Hyperactivity Disorder: Comparison of Medication Efficacy and Cost Brigham Young University BYU ScholarsArchive All Student Publications 2014-06-20 Attention Deficit Hyperactivity Disorder: Comparison of Medication Efficacy and Cost Robert M. David Karlen E. Luthy Janelle

More information

Information on Treating ADHD

Information on Treating ADHD Developed by the health care professionals of Child & Adolescent Mental Health Programs and reviewed by the Department of Learning and Development. ADHD: Being Informed Attention Deficit Hyperactivity

More information

3/7/2012. Educational Eligibility vs. Medical Diagnosis in Autism Spectrum Disorders

3/7/2012. Educational Eligibility vs. Medical Diagnosis in Autism Spectrum Disorders Educational Eligibility vs. Medical Diagnosis in Autism Spectrum Disorders Courtney Burnette, PhD Assistant Professor of Pediatrics CDD Autism Programs March 9, 2012 Pervasive Developmental Disorders (also

More information

Antipsychotic Medicines for Children and Teens. A Review of the Research for Parents and Caregivers

Antipsychotic Medicines for Children and Teens. A Review of the Research for Parents and Caregivers Antipsychotic Medicines for Children and Teens A Review of the Research for Parents and Caregivers Is This Information Right for the Child I Care For? Yes, if: A doctor has said your child (ages 1 through

More information

Psychotropic Medications

Psychotropic Medications Psychotropic Medications Medicating children and adolescents for psychiatric problems or learning disabilities continues to be an area of controversy. There are currently two opposing poles in this discussion.

More information

Psychopharmacotherapy for Children and Adolescents

Psychopharmacotherapy for Children and Adolescents TREATMENT GUIDELINES Psychopharmacotherapy for Children and Adolescents Guideline 7 Psychopharmacotherapy for Children and Adolescents Description There are few controlled trials to guide practitioners

More information

Perspective. Using Psychotropic Medications to Treat Patients Who Have Disabilities

Perspective. Using Psychotropic Medications to Treat Patients Who Have Disabilities A Perspective P E D I AT R I C Using Psychotropic Medications to Treat Patients Who Have Disabilities by Elizabeth Reeve, M.D. Volume 19, Number 4 2010 Primary-care providers have an important role to

More information

Autism Spectrum Disorder in DSM-5. Brian Reichow reichow@uchc.edu

Autism Spectrum Disorder in DSM-5. Brian Reichow reichow@uchc.edu Autism Spectrum Disorder in DSM-5 Brian Reichow reichow@uchc.edu Disclosure / Conflict of Interest Have no conflict of interest with any portion of today s talk. -Do receive royalties from lectures and

More information

ADHD. Attention-Deficit/Hyperactivity Disorder. Parents Medication Guide

ADHD. Attention-Deficit/Hyperactivity Disorder. Parents Medication Guide ADHD Parents Medication Guide Attention-Deficit/Hyperactivity Disorder Prepared by: American Academy of Child and Adolescent Psychiatry and American Psychiatric Association ADHD Parents Medication Guide

More information

Autism Spectrum Disorders: Medications

Autism Spectrum Disorders: Medications Patient Education UW Autism Center Center on Human Development and Disability Autism Spectrum Disorders: Medications Samuel H. Zinner, M.D. This handout covers issues about the use of medication in the

More information

MEDICATION INFORMATION FOR PARENTS - STIMULANTS

MEDICATION INFORMATION FOR PARENTS - STIMULANTS MEDICATION INFORMATION FOR PARENTS - STIMULANTS Patient Name is taking Medication Doctor's name If you have any questions about this medicine, please call the office at 631-3510. General Information about

More information

Algorithm for Initiating Antidepressant Therapy in Depression

Algorithm for Initiating Antidepressant Therapy in Depression Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression

More information

Anxiety, ADHD and Reading Disorders How They Interconnect and How to Help

Anxiety, ADHD and Reading Disorders How They Interconnect and How to Help Anxiety, ADHD and Reading Disorders How They Interconnect and How to Help Robert L Hendren, DO Professor of Psychiatry and Behavioral Science Co-Director, UCSF Dyslexia Center April 29, 2015 Anxiety People

More information

UCLA-NPI/VA PG-2 Child & Adolescent Psychiatry Course 2004-5. Week 3:Attention Deficit Hyperactivity Disorder

UCLA-NPI/VA PG-2 Child & Adolescent Psychiatry Course 2004-5. Week 3:Attention Deficit Hyperactivity Disorder UCLA-NPI/VA PG-2 Child & Adolescent Psychiatry Course 2004-5 Week 3:Attention Deficit Hyperactivity Disorder ADHD:Epidemiology Point Prevalence 2-18% M:F>= 2:1 ADHD Symptoms Cognitive (attention) Impulsivity

More information

SECTION M BEHAVIORAL HEALTH SERVICES

SECTION M BEHAVIORAL HEALTH SERVICES Phoenix Health Plan s (PHP) goal for its members is to ensure that behavioral health services are readily available for Title XIX (Medicaid) and the Title XXI (KidsCare) members. Comprehensive behavioral

More information

Recognition and Treatment of Depression in Parkinson s Disease

Recognition and Treatment of Depression in Parkinson s Disease Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,

More information

INFORMATION PAPER: THE PROPOSED CHANGES TO THE DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDERS (DSM-5)

INFORMATION PAPER: THE PROPOSED CHANGES TO THE DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDERS (DSM-5) INFORMATION PAPER: THE PROPOSED CHANGES TO THE DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDERS (DSM-5) What is the DSM-5? The Diagnostic and Statistical Manual of Mental Disorders (the DSM) is developed

More information

INFORMATION PAPER INTRODUCING THE DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER

INFORMATION PAPER INTRODUCING THE DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER INFORMATION PAPER INTRODUCING THE DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER What is the DSM-5? The Diagnostic and Statistical Manual of Mental Disorders (the DSM) is developed by the American

More information

New Guidelines for the Diagnosis and Treatment of ADHD

New Guidelines for the Diagnosis and Treatment of ADHD New Guidelines for the Diagnosis and Treatment of ADHD Mark L. Wolraich, M.D. CMRI/Shaun Walters Professor of Pediatrics University of Oklahoma Health Sciences Center Disclosures Lilly Consultant and Research

More information

Autism Spectrum Disorder. MAPA Fall Meeting October 9, 2015 Rebecca Klisz-Hulbert, M.D. Assistant Professor

Autism Spectrum Disorder. MAPA Fall Meeting October 9, 2015 Rebecca Klisz-Hulbert, M.D. Assistant Professor Autism Spectrum Disorder MAPA Fall Meeting October 9, 2015 Rebecca Klisz-Hulbert, M.D. Assistant Professor Learning Objectives Understand the core symptoms that comprise autism spectrum disorder Understand

More information

Medication Update. Depression, Anxiety, Insomnia, Agitation, Bipolar Disorder, and ADD

Medication Update. Depression, Anxiety, Insomnia, Agitation, Bipolar Disorder, and ADD Medication Update Depression, Anxiety, Insomnia, Agitation, Bipolar Disorder, and ADD General Principles: To consider meds there should be at least moderate impairment in function If considering meds also

More information

Childhood Rage: Diagnosis and Treatment Strategies for Severe Mood Dysregulation - Part 2: Diagnosis and Treatment

Childhood Rage: Diagnosis and Treatment Strategies for Severe Mood Dysregulation - Part 2: Diagnosis and Treatment Liberty University DigitalCommons@Liberty University Faculty Publications and Presentations Center for Counseling and Family Studies 2013 Childhood Rage: Diagnosis and Treatment Strategies for Severe Mood

More information

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP UNDERSTANDING AND TREATING ADHD ACTIVITY DESCRIPTION Pharmacists can play a pro-active role in the treatment of ADHD. Management of

More information

Rosalie Greenberg, MD

Rosalie Greenberg, MD Greenberg What s New in the Treatment of Child and Adolescent Attention Deficit Hyperactivity Disorder? Rosalie Greenberg, MD The past two decades have seen a dramatic increase in research into the biologic

More information

Children, Adolescents and Psychiatric Medication

Children, Adolescents and Psychiatric Medication Children, Adolescents and Psychiatric Medication Prepared by: Lee Combrinck-Graham, MD, Carolyn Crowder, PhD, Judith Pentz, MD, and Natalie Sadler, MD When your child is misbehaving do people ask you or

More information

THE NATIONAL INSTITUTE OF MENTAL HEALTH GUIDES TO:

THE NATIONAL INSTITUTE OF MENTAL HEALTH GUIDES TO: READING MATERIAL FOR THE FREE STATE SOCIAL WORK, LLC COURSE COMMON MENTAL DISORDERS: DIAGNOSIS AND TREATMENT THE NATIONAL INSTITUTE OF MENTAL HEALTH GUIDES TO: ATTENTION DEFICIT HYPERACTIVITY DISODER BIPOLAR

More information

DSM-5 and Effect On Diagnosis and Intervention Dr Ranjini S. Sivanesom Consultant Developmental Paediatrician Institute of Paediatrics, Hospital

DSM-5 and Effect On Diagnosis and Intervention Dr Ranjini S. Sivanesom Consultant Developmental Paediatrician Institute of Paediatrics, Hospital DSM-5 and Effect On Diagnosis and Intervention Dr Ranjini S. Sivanesom Consultant Developmental Paediatrician Institute of Paediatrics, Hospital Kuala Lumpur 22.04.14 History and Autism 1943: First described

More information

PSYCHIATRY FOR PCPs BIPOLAR DISORDER

PSYCHIATRY FOR PCPs BIPOLAR DISORDER PSYCHIATRY FOR PCPs BIPOLAR DISORDER David A Harrison, MD, PhD Assistant Professor Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Mood Disorders: Diagnosis & Treatment

More information

Mental Health Medications

Mental Health Medications Mental Health Medications National Institute of Mental Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Contents Mental Health Medications..............................................................1

More information

Handout 2 List of medications used to treat mental illness

Handout 2 List of medications used to treat mental illness Navigating Boundaries: Setting Sail With A Mentally Ill Client Handout 2 List of medications used to treat mental illness Information synthesized from www.drugs.com. Additional Information: CR following

More information

DSM 5 AND DISRUPTIVE MOOD DYSREGULATION DISORDER Gail Fernandez, M.D.

DSM 5 AND DISRUPTIVE MOOD DYSREGULATION DISORDER Gail Fernandez, M.D. DSM 5 AND DISRUPTIVE MOOD DYSREGULATION DISORDER Gail Fernandez, M.D. GOALS Learn DSM 5 criteria for DMDD Understand the theoretical background of DMDD Discuss background, pathophysiology and treatment

More information

Lamictal, lamotrigine Lithium, lithobid, eskalith Depakote, valproate Trileptal, oxcarbazepine Tegretol, equetro, carbamazepine Atypicals (aripiprazole, abilify, olanzapine, zyprexa, invega, risperdal,

More information

Objectives. The use of Psychotropics in Children

Objectives. The use of Psychotropics in Children Objectives The use of Psychotropics in Children Ashley E. Little, Pharm.D. Psychopharmacology Resident Nova Southeastern University College of Pharmacy Dade County Pharmacy Association To understand current

More information

Pervasive Developmental Disorders (PDD) A (Brief) History of Autism. Pervasive Developmental Disorders/ Autism Spectrum Disorders

Pervasive Developmental Disorders (PDD) A (Brief) History of Autism. Pervasive Developmental Disorders/ Autism Spectrum Disorders Pervasive Developmental Disorders: Differential Diagnosis, Treatment, & Research Update Julie Miller, Psy.D. Pediatric Neuropsychologist Pervasive Developmental Disorders/ Autism Spectrum Disorders 1 in

More information

Informational Series on Angelman Syndrome Behaviors

Informational Series on Angelman Syndrome Behaviors Informational Series on Angelman Syndrome Behaviors The most frequent requests for guidance and assistance from families of individuals with Angelman syndrome are related to behaviors. The Angelman syndrome

More information

BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS

BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

Early Morning Waking Excessively Orderly or Perfectionistic

Early Morning Waking Excessively Orderly or Perfectionistic COLLEGE OF MEDICINE Jacksonville 580 W 8 th St T-2 6 th Fl Ste 6005 6266 Dupont Station Ct Department of Psychiatry Jacksonville, FL 32209 Jacksonville, Fl 32217 Division of Adult Psychiatry Phone 904-383-1038

More information

Comorbid Problems in Children and Adults with ADHD: Current Medication Interventions

Comorbid Problems in Children and Adults with ADHD: Current Medication Interventions Comorbid Problems in Children and Adults with ADHD: Current Medication Interventions CANP State Conference March 22, 2013 Monterey, CA Susan R. Opas, PhD, CPNP, CPMHS Workshop Objectives Review defining

More information

Moody Kids, Bipolar Disorder, and Medication Treatment Strategies. Learning Objectives. Mood Episodes. Irritability and Anger are Nonspecific Symptoms

Moody Kids, Bipolar Disorder, and Medication Treatment Strategies. Learning Objectives. Mood Episodes. Irritability and Anger are Nonspecific Symptoms Moody Kids, Bipolar Disorder, and Medication Treatment Strategies May 6, 2016 Dara Sakolsky, MD, PhD Associate Medical Director, STAR Clinic Assistant Professor of Psychiatry University of Pittsburgh Medical

More information

Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder Attention Deficit Hyperactivity Disorder A detailed booklet that describes the symptoms, causes, and treatments, with information on getting help and coping with ADHD. 2016 Contents What is Attention Deficit

More information

ADHD Target Symptom Worksheet

ADHD Target Symptom Worksheet Patient Name: ADHD Target Symptom Worksheet Today's Date: Age: Sex MR #M Parents' Names Potential Targets Core symptoms Inattention Hyperactivity Impulsivity Associated symptoms Anxiety Depression Oppositional

More information